Menu

Bluejay Diagnostics, Inc. BJDX

Full chart Compare
Set alert

Price alert · BJDX

All alert types
2.35 USD +0.16 (+7.31%)

At closeNov 6, 2026, 4:00 PM EST

2.30 -0.05 -2.13%

After hours · Nov 6, 4:00 PM ET

2.22 Day range 2.41
1.84 52-week range 28.00
YTD
-77.98%
1 year
-90.76%

Revenue & Expenses

Other Income → Expenses: $20.83KExpenses → Selling, General & Admin: $5.21MExpenses → Research & Development: $4.15MGross Profit → Expenses: $48.91KRevenue → Gross Profit: $48.91KRevenue → Cost of Revenue: $200.13KNet Loss → Expenses: $9.30MOther Income$20.83KGross Profit$48.91KNet Loss$9.30MCost of Revenue$200.13KExpenses$9.37MSelling, General & Admin$5.21MResearch & Development$4.15MRevenue$249.04K

Latest period ending Dec 31, 2025 · select a line to chart its full history

BJDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-6.95M-7.17M-10.31M-9.32M-3.23M
-6.85M-7.72M-9.95M-9.30M-3.49M
-61.00-1,827.00-58,104.00-59,008.00-52,480.00
BJDX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
5.16M4.30M2.21M10.11M19.05M
7.12M6.66M4.87M13.52M21.02M
1.14M927.92K1.97M1.98M637.16K
120.21K222.25K352.98K492.62K0
5.98M5.73M2.89M11.54M20.38M
BJDX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-6.05M-7.82M-8.31M-7.74M-4.37M
-173.74K-306.78K-704.17K-1.20M-23.95K
7.09M10.22M1.11M8.07K22.53M
-173.74K-306.78K-704.17K-1.20M-23.95K
862.93K2.09M-7.91M-8.93M18.14M